Combined [18F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Detection of Recurrent, 131I-Negative Thyroid Cancer

被引:0
|
作者
Steven E. Finkelstein
Perry W. Grigsby
Barry A. Siegel
Farrokh Dehdashti
Jeffrey F. Moley
Bruce L. Hall
机构
[1] Washington University School of Medicine,Department of Surgery
[2] Washington University School of Medicine,Department of Radiation Oncology
[3] Mallinckrodt Institute of Radiology,Division of Nuclear Medicine
[4] Washington University School of Medicine,Alvin J. Siteman Cancer Center
[5] Washington University School of Medicine,undefined
来源
关键词
Thyroid cancer; I Scintigraphy; FDG-PET; FDG-PET/CT;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:286 / 292
页数:6
相关论文
共 50 条
  • [1] Combined [18F]fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer
    Finkelstein, Steven E.
    Grigsby, Perry W.
    Siegel, Barry A.
    Dehdashti, Farrokh
    Moley, Jeffrey F.
    Hall, Bruce L.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (01) : 286 - 292
  • [2] Characteristics of malignant thyroid lesions on [18F] fluorodeoxyglucose (FDG)-Positron emission tomography (PET)/Computed tomography (CT)
    Nasr, Hatem
    Farghaly, Hussein
    Alqarni, Abdullah
    Al-Salem, Seham
    Sayed, Mohamed
    [J]. EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2021, 8
  • [3] Characteristics of malignant thyroid lesions on [18F]Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT)
    Nasr, H.
    Farghaly, H.
    Alqarni, A.
    Al-Salem, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S322 - S323
  • [4] The diagnostic value of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography-computed tomography (PET/CT) for urachal cancer
    Stokkel, L. E.
    Stokkel, M. P.
    Donswijk, M. L.
    Lahaye, M. J.
    Van Rhijn, B. W. G.
    Mertens, L.
    [J]. EUROPEAN UROLOGY, 2021, 79 : S963 - S964
  • [5] The use of [18F]-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) for predicting recurrence in cervical cancer patients
    Brunette, L.
    Mehta, A.
    Lieber, D.
    Bonyadlou, S.
    Lin, Y.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 389 - 389
  • [6] Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer
    Thrall, Melissa M.
    DeLoia, Julie A.
    Gallion, Holly
    Avril, Norbert
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 105 (01) : 17 - 22
  • [7] Inflammatory pseudotumour of the spleen: the findings on F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)
    Ryu, Je Seock
    Um, Jun Won
    Min, Byung Wook
    [J]. ANZ JOURNAL OF SURGERY, 2010, 80 (09) : 650 - 652
  • [8] Usefulness of CA125 and its kinetic parameters and positron emission tomography/computed tomography (PET/CT) with fluorodeoxyglucose [18F] FDG) in the detection of recurrent ovarian cancer
    Palomar Munoz, Azahara
    Cordero Garcia, Jose Manuel
    Talavera Rubio, Prado
    Garcia Vicente, Ana M.
    Gonzalez Garcia, Beatriz
    Bellon Guardia, Maria Emiliana
    Soriano Castrejon, Angel
    Aranda Aguilard, Enrique
    [J]. MEDICINA CLINICA, 2018, 151 (03): : 97 - 102
  • [9] Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck:: is it likely to be superior?
    Brouwer, J
    de Bree, R
    Comans, EFI
    Castelijns, JA
    Hoekstra, OS
    Leemans, CR
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2004, 261 (09) : 479 - 483
  • [10] Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior?
    Jolijn Brouwer
    Remco de Bree
    Emile F. I. Comans
    Jonas A. Castelijns
    Otto S. Hoekstra
    C. René Leemans
    [J]. European Archives of Oto-Rhino-Laryngology and Head & Neck, 2004, 261 : 479 - 483